Mesabi Trust
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $304.3M
- Price
- $23.19
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.26%
- Volume
- 24.7K
About
Mesabi Trust, a royalty trust, engages in iron ore mining business in the United States. The company was incorporated in 1961 and is based in New York, New York.
Quick stats
Shares outstanding13.1M
Computed float13.1M
Float / shares99.9%
Key info
SectorBasic Materials
IndustrySteel
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000065172
Websitehttps://mesabi-trust.com
AI Summary
AI-generated1/13
majorbullishclinical trial
Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain
Mesoblast completed patient treatment in its pivotal Phase 3 trial of rexlemestrocel-L for chronic low back pain, randomizing 350 patients.
The trial is designed to confirm durable pain reduction at 12 months, with top-line results expected in mid-2027 under the FDA's RMAT designation pathway.
Management cited a potential peak revenue opportunity exceeding $10 billion in the U.S., given the high prevalence of degenerative disc disease.